Is hepatic arterial infusion chemotherapy effective treatment for advanced hepatocellular carcinoma resistant to transarterial chemoembolization?

doi:10.3748/wjg.v18.i16.1933

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 16

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4444)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

385

HTML

3676

Figures (1-4)

204

Tables (1-3)

179

Sum=4444

Apr 28, 2012 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Apr 28, 2012; 18(16): 1933-1939
Published online Apr 28, 2012. doi: 10.3748/wjg.v18.i16.1933

Is hepatic arterial infusion chemotherapy effective treatment for advanced hepatocellular carcinoma resistant to transarterial chemoembolization?

Hiroyuki Kirikoshi, Masato Yoneda, Hironori Mawatari, Koji Fujita, Kento Imajo, Shingo Kato, Kaori Suzuki, Noritoshi Kobayashi, Kensuke Kubota, Shin Maeda, Atsushi Nakajima, Satoru Saito

Hiroyuki Kirikoshi, Masato Yoneda, Hironori Mawatari, Koji Fujita, Kento Imajo, Shingo Kato, Kaori Suzuki, Noritoshi Kobayashi, Kensuke Kubota, Shin Maeda, Atsushi Nakajima, Satoru Saito, Gastroenterology Division, Yokohama City University Graduate School of Medicine, 3-9 Fuku-ura, Kanazawa-ku, Yokohama 236-0004, Japan

Author contributions: Kirikoshi H performed the literature review and drafted the manuscript, with contributions from Nakajima A and Saito S; Kirikoshi H, Saito S, Yoneda M, Mawatari H, Fujita K and Imajo K performed this combined therapy and follow up for this patients; Kato S, Suzuki K, Kobayashi N, Kubota K, and Maeda S collected the clinical data; all authors read and approved the final manuscript.

Supported by A Grant-in-Aid for research on the Third Term Comprehensive Control Research for Cancer from the Ministry on Health, Labour and Welfare, Japan, to Atsushi Nakajima; a grant from the National Institute of Biomedical Innovation (NBIO) to Atsushi Nakajima; a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan (KIBAN-B), to Atsushi Nakajima, (KIBAN-C), to Satoru Saito; the grant program, “Collaborative Development of Innovative Seeds,” from the Japan Science and Technology Agency (JST)

Correspondence to: Satoru Saito, Associate Professor, Gastroenterology Division, Yokohama City University Graduate School of Medicine, 3-9 Fuku-ura, Kanazawa-ku, Yokohama 236-0004, Japan. ssai1423@yokohama-cu.ac.jp

Telephone: +81-45-7872640 Fax: +81-45-7843546

Received: September 13, 2011
Revised: November 24, 2011
Accepted: February 27, 2012
Published online: April 28, 2012

Core Tip